EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Self-injection experiences among transgender people on injectable gender-affirming hormone therapy: A narrative review

Jordan M Rowe, Sarah McBane, Jackson T Warner, Lauren R Cirrincione

Journal of the American Pharmacists Association · 2025-07 · 65 (4) · 102405

DOI: 10.1016/j.japh.2025.102405 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Pharmacists Association, 2025-07. Verfasst von Jordan M Rowe und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Transgender Persons, Testosterone, Estradiol. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NCATS NIH HHS, NCATS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transgender and gender-diverse (TGD) people may self-administer injectable estradiol or testosterone therapy for gender-affirming hormone therapy (GAHT). Knowledge about injection-related safety and injection adherence for TGD people remains to be determined. OBJECTIVES: To determine the types of injection-related safety issues and medication adherence issues reported in the literature for TGD people on injectable GAHT. Our secondary objective was to identify opportunities for pharmacists to enhance the self-injection experience for TGD people on injectable GAHT. METHODS: We examined the literature to determine the types of issues TGD people experience when prescribed injectable GAHT. We searched for English language publications in PubMed and Google Scholar from inception to 5 August 2024 (e.g., "transgender," "nonbinary," "self-inject∗," "estrogens," and "testosterone") and included original research publications that assessed 1 of 3 injection-related domains: Safety (injection site-related reactions or pain, psychological safety around injections), injection-related medication administration (individual self-injection practices and preferences including family or caregiver support administering injections, access to appropriate injection supplies, continuation of injections, patient-reported comfort) and teaching and assessment of injection practices by a pharmacist or other health care provider (clinic- or pharmacy-based injection counseling or follow-up assessments). We excluded articles that did not describe whether GAHT was self-injected and publications about long-acting injectable testosterone undecanoate, as trained providers administer this medication. RESULTS: Seven publications discussed at least 1 of the 3 injection-related domains. Investigators used various methods for assessing these elements across publications. Although self-injected GAHT was well-tolerated overall, most publications reported injection site reactions that were managed while continuing self-injected GAHT. Gaps included comprehensive teaching and assessment of individual self-injection practices long-term. CONCLUSION: Based on the types of injection-related challenges identified, pharmacists, as one of the most accessible health care providers in the United States, are well-positioned to intervene and improve the experience of patients using injectable GAHT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsTestosteroneEstradiolHumansSelf AdministrationInjectionsMalePharmacistsMedication AdherenceFemale

Substanzen

TestosteroneEstradiol

Förderung

  • NIGMS NIH HHS
  • NCATS NIH HHS
  • NCATS
  • National Institutes of Health
  • NIH NIGMS

Zitieren

APA

Rowe, J. M., McBane, S., Warner, J. T., & Cirrincione, L. R. (2025). Self-injection experiences among transgender people on injectable gender-affirming hormone therapy: A narrative review. Journal of the American Pharmacists Association, 65(4), 102405. https://doi.org/10.1016/j.japh.2025.102405

Vancouver

Rowe JM, McBane S, Warner JT, Cirrincione LR. Self-injection experiences among transgender people on injectable gender-affirming hormone therapy: A narrative review. Journal of the American Pharmacists Association. 2025;65(4):102405. doi:10.1016/j.japh.2025.102405

BibTeX
@article{Rowe2025,
  author = {Rowe, Jordan M and McBane, Sarah and Warner, Jackson T and Cirrincione, Lauren R},
  title = {Self-injection experiences among transgender people on injectable gender-affirming hormone therapy: A narrative review},
  journal = {Journal of the American Pharmacists Association},
  year = {2025},
  volume = {65},
  number = {4},
  pages = {102405},
  doi = {10.1016/j.japh.2025.102405}
}
Kostenlos starten →